Daiichi Sankyo to pay $39 million to settle U.S. kickback claims: DOJ
The U.S. subsidiary of global pharmaceutical company Daiichi Sankyo Co Ltd has agreed to pay $39 million to the U.S. government and state Medicaid programs to settle claims it paid doctors kickbacks to prescribe its drugs, the Department of Justice said on Friday.